All Reports and Publications

page 1 of 6

This survey should take no more than 3 minutes to complete. We will use your answers to improve the experience for the people who use the OIG.HHS.GOV website. This survey is conducted in accordance with Executive Order 12862. With the possible exception of email address, the survey does not collect personal information.

For general inquires, contact us. Do not use this form to report fraud or abuse

Why did you visit OIG.HHS.GOV today? *

To learn about HHS-OIG

To learn more about consumer alerts, or fraud and abuse laws

To file a complaint or report fraud

To research excluded individuals and entities (LEIE database)

To find an HHS-OIG report or recommendation

To learn more about compliance

Other

Enter other text

page 2 of 6

What specifically were you looking for?

Do not include personal information.

page 3 of 6

How was your experience? – Select any that apply.

I can't find what I need.

Information was confusing.

Information is missing, no longer valid, or not relevant.

I can't finish what I need to do.

Other

Enter other text

page 4 of 6

How can we improve your experience with the HHS-OIG website?

Do not include personal information.

page 6 of 6

Would you like us to contact you for your feedback on ways to improve the OIG.HHS.GOV website for visitors?

Yes - you may contact me

No - do not contact me

If you provide your email address, it may be used to contact you about future feedback studies about ways to improve OIG.HHS.GOV. Your email address will not be linked to your responses and will be deleted upon the completion of any participation in feedback studies or after one year of inactivity. You will only be contacted about future feedback studies, not for other purposes.

Please provide your email if you would like us to contact you

All Reports and Publications

Medicare Part D Spending for 10 Selected Diabetes Drugs Totaled $35.8 Billion in 2023, an Increase of 364 Percent From 2019

Not All Medicare Enrollees Are Continuing Treatment for Opioid Use Disorder

Providers Used Medicare Part D Eligibility Verification Transactions for Permissible Purposes

Medicare Part D Paid Millions for Drugs for Which Payment Was Available Under the Medicare Part A Skilled Nursing Facility Benefit

Medicare and Medicaid Enrollees in Many High-Need Areas May Lack Access to Medications for Opioid Use Disorder

Medicare and Some Enrollees Paid Substantially More When Stelara Was Covered Under Part D Versus Part B

Part D Plans Generally Include Drugs Commonly Used by Dual-Eligible Enrollees: 2024

Department of Health and Human Services Met Many Requirements, but It Did Not Fully Comply With the Payment Integrity Information Act of 2019 and Applicable Improper Payment Guidance for the Fiscal Year 2023

The Consistently Low Percentage of Medicare Enrollees Receiving Medication to Treat Their Opioid Use Disorder Remains a Concern

The Risk of Misuse and Diversion of Buprenorphine for Opioid Use Disorder in Medicare Part D Continues to Appear Low: 2022

Department of Health and Human Services Met Many Requirements, but It Did Not Fully Comply With the Payment Integrity Information Act of 2019 and Applicable Improper Payment Guidance for the Fiscal Year 2022

The Risk of Misuse and Diversion of Buprenorphine for Opioid Use Disorder Appears to Be Low in Medicare Part D

Medicare Part D Plan Sponsors and CMS Did Not Ensure That Transmucosal Immediate-Release Fentanyl Drugs Were Dispensed Only to Beneficiaries Who Had a Cancer Diagnosis

Long-Term Trends of Psychotropic Drug Use in Nursing Homes

CMS Generally Ensured That Medicare Part C and Part D Sponsors Did Not Pay Ineligible Providers for Services to Medicare Beneficiaries

Part D Plan Preference for Higher-Cost Hepatitis C Drugs Led to Higher Medicare and Beneficiary Spending

The Centers for Medicare & Medicaid Services Had Policies and Procedures in Place To Mitigate Vulnerabilities in a Timely Manner, but Improvements Are Needed

Las imprecisiones en los datos de raza y origen étnico de Medicare dificultan la evaluación de disparidades en la salud

Inaccuracies in Medicare's Race and Ethnicity Data Hinder the Ability To Assess Health Disparities

Department of Health and Human Services Met Many Requirements, but It Did Not Fully Comply With the Payment Integrity Information Act of 2019 and Applicable Improper Payment Guidance for the Fiscal Year 2021

Thank you

Error

All Reports and Publications

Filters